NCT03209700View on ClinicalTrials.gov

Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 20, 2017

Primary Completion Date

December 10, 2019

Study Completion Date

December 10, 2019

Conditions
Perianal FistulaCryptoglandular Perianal FistulaCrohn's Perianal Fistula
Interventions
DRUG

MSC-AFP

Eligible patients will be treated with a fistula plug that has been coated with autologous mesenchymal stromal cells.

Trial Locations (1)

55905

Mayo Clinic in Minnesota, Rochester

All Listed Sponsors
lead

William A. Faubion, M.D.

OTHER

NCT03209700 - Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas | Biotech Hunter | Biotech Hunter